Design of randomized, double-blind, evaluation in secondary stroke prevention comparing the efficacy and safety of the oral thrombin inhibitor dabigatran etexilate vs. acetylsalicylic acid in patients with Embolic Stroke of Undetermined Source (RESPECT ESUS) - Diener, HC; Easton, JD; Granger, CB (Int J Stroke, 2015)
et al.